• Hero Banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Buying or Selling a Practice
Hospital Design
Leadership & Personal Growth
Personnel Management
Practice Finances
Practice Operations
Technology
Wellbeing & Lifestyle
Continuing Education
Conferences
Live Conferences
Conference News
Conference Proceedings
Resources
CBD in Pets
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Just approved: Generic clomipramine for canine separation anxiety

November 1, 2019
dvm360 Staff
dvm360, dvm360 December 2019, Volume 50, Issue 12

Make way for a potentially less expensive option to add to your behavior management arsenal.

The tricyclic antidepressant Clomicalm (clomipramine hydrochloride, Elanco) was approved just over 20 years ago for veterinary use. Today, the FDA announced on its website that a generic version of clomipramine has been approved by the Center for Veterinary Medicine.

Clomipramine, used in veterinary medicine as part of a comprehensive behavioral management program to treat separation anxiety in dogs over 6 months of age, reduces the clinical signs of separation anxiety by increasing brain serotonin levels to balance out mood.

Although exact prevalence data are unavailable, experts indicate that separation anxiety affects an estimated 20% to 40% of dogs that present to veterinary behavior specialists.

To gain FDA approval, the manufacturer, Mizner Bioscience, LLC, located in Boca Raton, Fla., submitted an abbreviated new animal drug application that showed via an in vivo blood-level study that the 20-mg tablet of its generic version of clomipramine is bioequivalent to the 20-mg tablet of Clomicalm. Based on data from dissolution studies, a biowaiver was granted for the 5-, 40- and 80-mg generic tablets.

Advertisement

dvm360 spoke with Amy L. Pike, DVM, DACVB, owner of the Animal Behavior Wellness Center in northern and central Virginia, to get her take on this announcement. Although the availability of a generic will benefit clients financially-Clomicalm can be expensive, especially for large-breed dogs, she said-one concern with all generic medication is that the manufacturer is not required to prove safety or efficacy, only that the drug contains the active ingredient.

"With psychotropic medication, we often find that response to brand can be different than response to generic," Dr. Pike said. "Many human psychiatrists find this to be true for their patients as well."

The recommended daily dose of clomipramine (administered once or twice daily) is 2 to 4 mg/kg (0.9–1.8 mg/lb). Available by prescription only, clomipramine is packaged in color-coded bottles containing 30 tablets in 5-, 20-, 40- and 80-mg doses. 

download issueDownload Issue: dvm360 December 2019

Related Content:

ProductsRegulatoryBehaviorBreaking NewsAnimal Welfaredvm360 December 2019
Humanimal Trust joins World Federation for Animals
Humanimal Trust joins World Federation for Animals
Shelters United to launch beta test for pet adoption app and website
Shelters United to launch beta test for pet adoption app and website
ASPCA celebrates caring for 10,000th foster kitten in Los Angeles County
ASPCA celebrates caring for 10,000th foster kitten in Los Angeles County

Advertisement

Latest News

Sand cat triplets born North Carolina Zoo

Hannah Pet Hospital names new CEO

Humanimal Trust joins World Federation for Animals

News wrap-up: This week’s headlines, plus Kansas State University College of Veterinary Medicine presents Temple Grandin, PhD, MS, with an honorary degree

View More Latest News
Advertisement